---
$id: https://graph.org.ai/products/commodity/51312107
$type: Product
source: UNSPSC
code: "51312107"
title: "Lodoxamide tromethamine"
class: "51312100"
classTitle: "Antihistamine or H1 blocker cyclic s-oxides and dibenzazepines and dibenzoxepins and glyoxylates"
family: "51310000"
familyTitle: "Antihistamines or H1 blockers"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lodoxamide tromethamine

**UNSPSC Code**: 51312107
**Class**: [Antihistamine or H1 blocker cyclic s-oxides and dibenzazepines and dibenzoxepins and glyoxylates](Antihistamine or H1 blocker cyclic s-oxides and dibenzazepines and dibenzoxepins and glyoxylates.mdx)
**Family**: [Antihistamines or H1 blockers](../Antihistamines or H1 blockers.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a mast cell stabilizer, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 50LV9A548L. European Medicines Agency schedules Lodoxamide trometamol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02964MIG. Lodoxamide tromethamine generally arises in the molecular formula C11H6CLN3O6.2C4H11NO3. The term 'lodoxamide tromethamine' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule lodoxamide tromethamine under HS 29269095 and SITC 51484. As of Q4 2014, LODOXAMIDE TROMETHAMINE remains US FDA's Preferred Term for this commodity. Lodoxamide tromethamine bears US NLM identifiers UMLS ID C0065148 and NCI Concept Code C29160. SMILES: C1C(CC(C(C1NC(=O)C(=O)O)CL)NC(=O)C(=O)O)C#N.C(C(CO)(CO)N)O.C(C(CO)(CO)N)O.

